CardioArt Technologies — Israeli Startup

About

CardioArt Technologies is developing technology for the noninvasive measurement of various hemodynamic parameters. The technology enables both medical personnel and patients to obtain hemodynamic parameters noninvasively, yielding a substantial reduction in the risks involved with procedures such as right heart catheterization.

The company's first product line is focused on the treatment of patients with congestive heart failure.

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is the primary focus of CardioArt Technologies' technology development?

CardioArt Technologies is developing technology for the noninvasive measurement of various hemodynamic parameters, aiming to reduce risks associated with procedures like right heart catheterization.

When was CardioArt Technologies founded?

CardioArt Technologies was founded in February 2005.

What is the current operational status of CardioArt Technologies?

CardioArt Technologies is currently inactive, having ceased to operate in March 2020.

What is CardioArt Technologies' first product line focused on?

CardioArt Technologies' first product line is focused on the treatment of patients with congestive heart failure.

Where is CardioArt Technologies headquartered?

CardioArt Technologies is headquartered in Or Yehuda, Israel.

What is the employee count for CardioArt Technologies?

CardioArt Technologies has 2 employees.

Has CardioArt Technologies received any grants?

Yes, CardioArt Technologies has received a grant from the IIA.

What is the primary sector of CardioArt Technologies?

CardioArt Technologies' primary sector is Health Tech & Life Sciences, specifically focusing on Medical Devices and Diagnostics Devices.

Sectors & technology

Primary sector

Health Tech & Life Sciences

Sub-sectors

Health Tech & Life SciencesMedical DevicesDiagnostics Devices

Technologies

Simulation & Imaging

Target customers

Healthcare & Life SciencesHealthcareProviders

Business model

B2B

CardioArt Technologies — Full Company Profile (machine-readable)

Noninvasive Measurement of Hemodynamic Parameters

About

Facts

Name	CardioArt Technologies
Slug	cardioart-technologies
Type	Israeli Startup
Founded	2005
HQ city	Or Yehuda
HQ country	IL
Primary sector	[object Object]
Sectors	[object Object], [object Object], [object Object]
Business models	B2B
Target customers	[object Object], [object Object], [object Object]
Status	inactive
Current stage	Pre-Funding
Public stage	Pre-Funding
Total raised (USD)	0
Crunchbase ID	cardioart-technologies
Israeli Companies Registrar	513653931

Team (2)

Name	Role	LinkedIn
Eyal Karev
Dan Furman

Intelligence Q&A

What is the primary focus of CardioArt Technologies' technology development?

CardioArt Technologies is developing technology for the noninvasive measurement of various hemodynamic parameters, aiming to reduce risks associated with procedures like right heart catheterization.

When was CardioArt Technologies founded?

CardioArt Technologies was founded in February 2005.

What is the current operational status of CardioArt Technologies?

CardioArt Technologies is currently inactive, having ceased to operate in March 2020.

What is CardioArt Technologies' first product line focused on?

CardioArt Technologies' first product line is focused on the treatment of patients with congestive heart failure.

Where is CardioArt Technologies headquartered?

CardioArt Technologies is headquartered in Or Yehuda, Israel.

What is the employee count for CardioArt Technologies?

CardioArt Technologies has 2 employees.

Has CardioArt Technologies received any grants?

Yes, CardioArt Technologies has received a grant from the IIA.

What is the primary sector of CardioArt Technologies?

CardioArt Technologies' primary sector is Health Tech & Life Sciences, specifically focusing on Medical Devices and Diagnostics Devices.

About

Company Intelligence Q&A

Sectors & technology

Tags

Generate Slim Page